This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
We have now added a new section called the "Assay History List" to the "At A Gla...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...